Vtv Theraptcs Cl A (VTVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VTVT | AZN | AMGN | GILD | BMY |
| Company | Vtv Theraptcs Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 40.74 | 195.21 | 345.52 | 134.02 | 58.84 |
| High | 40.94 | 196.64 | 350.67 | 134.68 | 59.25 |
| Low | 37.21 | 194.42 | 345.50 | 132.79 | 58.64 |
| Latest | 37.17 | 193.13 | 348.49 | 133.52 | 59.01 |
| Change | -3.28 | -1.68 | +2.57 | +0.62 | +0.21 |
| % Change | -8.11% | -0.86% | +0.74% | +0.47% | +0.36% |
| Volume | 39,701 | 726,641 | 701,285 | 1,274,404 | 1,960,116 |
| 20-Day Average Volume | 49,790 | 1,828,232 | 2,376,456 | 5,051,276 | 9,256,500 |
| Previous Close | 40.45 | 194.81 | 345.92 | 132.90 | 58.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 38.32 | 199.16 | 349.38 | 137.97 | 59.18 |
| 20-Day Raw Stochastic | 27.58% | 48.71% | 61.51% | 18.14% | 36.96% |
| 20-Day Relative Strength | 49.71 | 47.46 | 47.73 | 39.67 | 50.37 |
| Weighted Alpha | +72.13 | +37.31 | +23.84 | +25.39 | +27.14 |
| Today's Opinion | 88% Buy | 72% Buy | 56% Buy | 24% Buy | 48% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Last Month's Opinion | 72% Buy | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.39% since 04/16/26 | -2.86% since 04/16/26 | +0.19% since 04/16/26 | -3.68% since 04/16/26 | +0.19% since 04/16/26 |
| Low | 36.01 on 04/17/26 | 194.64 on 04/23/26 | 340.06 on 04/21/26 | 131.34 on 04/22/26 | 57.79 on 04/21/26 |
| High | 41.35 on 04/22/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 139.76 on 04/17/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | -0.05% since 03/23/26 | +5.79% since 03/23/26 | +0.08% since 03/23/26 | -2.83% since 03/23/26 | +3.63% since 03/23/26 |
| Low | 34.20 on 03/24/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.34 on 04/22/26 | 56.45 on 03/24/26 |
| High | 43.09 on 04/02/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +9.23% since 01/23/26 | +4.75% since 01/23/26 | +1.54% since 01/23/26 | -1.82% since 01/23/26 | +8.09% since 01/23/26 |
| Low | 28.84 on 02/06/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.34 on 04/22/26 | 54.21 on 01/29/26 |
| High | 43.09 on 04/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +78.79% since 10/23/25 | +16.74% since 10/23/25 | +19.52% since 10/23/25 | +10.53% since 10/23/25 | +34.77% since 10/23/25 |
| Low | 19.50 on 10/24/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 44.00 on 01/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 159,328 | 302,132,384 | 186,687,840 | 164,958,400 | 120,054,016 |
| Shares Outstanding, K | 3,939 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -26,970,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -7,140,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.40 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.58 on 03/10/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/21/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.37 | 15.78 | 16.35 | 9.66 |